| Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease (NCT01604213) | Sheba Medical Center | 2012-09-01 |
| Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus (NCT01316861) | EMS | 2012-09-01 |
| Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus (NCT01689142) | Sanofi | 2012-09-01 |
| Using Peer Mentors to Support PACT Team Efforts to Improve Diabetes Control (NCT01651117) | VA Office of Research and Development | 2012-09-01 |
| Effects of Triacylglycerol Structure on Gut Hormones and Haemostatic Markers (NCT01906359) | Malaysia Palm Oil Board | 2012-09-01 |
| Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM (NCT01525225) | AstraZeneca | 2012-09-01 |
| Vitamin D, Cardiovascular Disease, and African Americans (NCT01655810) | Washington University School of Medicine | 2012-08-13 |
| Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency (NCT01513369) | GWT-TUD GmbH | 2012-08-01 |
| Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy (NCT01676220) | Sanofi | 2012-08-01 |
| Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients. (NCT01649466) | Novartis Pharmaceuticals | 2012-08-01 |
| Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants (NCT01662999) | AstraZeneca | 2012-08-01 |
| A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes (NCT01665352) | vTv Therapeutics | 2012-08-01 |
| A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis (NCT01576887) | Biogen | 2012-07-31 |
| A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296) (NCT01557504) | Merck Sharp & Dohme LLC | 2012-07-18 |
| Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253) (NCT01614769) | Merck Sharp & Dohme LLC | 2012-07-18 |
| A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254) (NCT01590797) | Merck Sharp & Dohme LLC | 2012-07-10 |
| A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253) (NCT01590771) | Merck Sharp & Dohme LLC | 2012-07-09 |
| Treatment of Diabetes After Gastric Bypass With Sitagliptin (NCT01512797) | Blandine Laferrere | 2012-07-01 |
| PK Study of Dapagliflozin in Pediatric Subjects With T2DM (NCT01525238) | AstraZeneca | 2012-07-01 |
| A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus (NCT01648582) | Eli Lilly and Company | 2012-07-01 |
| Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM (NCT01658501) | PhaseBio Pharmaceuticals Inc. | 2012-07-01 |
| Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus (NCT01645332) | Dexa Medica Group | 2012-07-01 |
| A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus (NCT01644500) | Eli Lilly and Company | 2012-07-01 |
| A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142) (NCT01582308) | Merck Sharp & Dohme LLC | 2012-06-21 |
| A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone (NCT01555164) | Gilead Sciences | 2012-06-01 |
| Text to Move (TTM)Study (NCT01569243) | Massachusetts General Hospital | 2012-06-01 |
| A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002) (NCT01614782) | Merck Sharp & Dohme LLC | 2012-06-01 |
| Effect of Vitamin D Supplementation on the Metabolic Control and Body Composition of Type 2 Diabetes Subjects in Ajman (UAE) (NCT02101151) | Rashid Centre for Diabetes and Research | 2012-06-01 |
| A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients (NCT01672762) | Astellas Pharma Inc | 2012-05-25 |
| Efficacy Study of the DIAMOND System to Treat Type 2 Diabetes Mellitus (NCT01529216) | MetaCure Limited | 2012-05-01 |
| Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DM (NCT01677299) | Elcelyx Therapeutics, Inc. | 2012-05-01 |
| Effects of 5-day Statin Withdrawal on Endothelial Progenitor Cells and Inflammatory Markers in Type 2 Diabetic Patients (NCT01600690) | University of Padova | 2012-05-01 |
| Pilot Study of the Effects of Erythritol on Endothelial Function in Patients With Type 2 Diabetes Mellitus (NCT01609088) | Boston University | 2012-05-01 |
| Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II) (NCT01510093) | Aarhus University Hospital | 2012-05-01 |
| Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes (NCT01572649) | Sanofi | 2012-05-01 |
| The Effects of Immersion in Dead Sea Water on Glucose Levels in Type 2 Diabetes Mellitus Patients (NCT01580852) | Victor Novack | 2012-05-01 |
| Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin (NCT01596504) | Sanofi | 2012-05-01 |
| Telecoaching of People With Type 2 Diabetes in Primary Care (NCT01612520) | KU Leuven | 2012-04-01 |
| Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients (NCT01490918) | The Catholic University of Korea | 2012-04-01 |
| Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes Mellitus (NCT01582230) | Novartis Pharmaceuticals | 2012-04-01 |
| A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus (NCT01584232) | Eli Lilly and Company | 2012-04-01 |
| Go Girls! Fitness Support Group Intervention Effectiveness Study (NCT02117063) | University of Virginia | 2012-04-01 |
| Effect of Iron Reduction by Phlebotomy for Type 2 Diabetes (NCT02468037) | University of Utah | 2012-04-01 |
| VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus (NCT01528254) | Novartis Pharmaceuticals | 2012-03-30 |
| Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM) (NCT01560546) | Marianne Andersen | 2012-03-01 |
| Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment (NCT01555008) | Lexicon Pharmaceuticals | 2012-03-01 |
| A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus (NCT01558271) | Eli Lilly and Company | 2012-03-01 |
| Shared Decision Making Between Patients and GPs in the Treatment of Type 2 Diabetes in Primary Care. (NCT02285881) | UMC Utrecht | 2012-03-01 |
| NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria (NCT01547897) | TME Pharma AG | 2012-03-01 |
| Metabolic Effects of Hydroxychloroquine (NCT02026232) | Washington University School of Medicine | 2012-03-01 |
| The Impact of Reformulated Foods on Cardiovascular Risk Factors (NCT01645995) | University of Reading | 2012-03-01 |
| Study of PaQ™ (a Simple Patch on Insulin Delivery Device) in Patients With Type 2 Diabetes Mellitus (NCT01535612) | CeQur Corporation | 2012-03-01 |
| The Contribution of Incretin Hormones to Post-prandial Glucose Metabolism After Roux-en-Y Gastric Bypass (NCT01843881) | Adrian Vella | 2012-03-01 |
| Japanese Phase 1 Multiple Ascending Dose Study (NCT01515202) | Bristol-Myers Squibb | 2012-03-01 |
| Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136) (NCT01545388) | Merck Sharp & Dohme LLC | 2012-02-23 |
| Remission Rates of New Type 2 Diabetes With Weight Loss and Exercise (NCT02065544) | University of Vermont | 2012-02-01 |
| Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes (NCT01392898) | Radboud University Medical Center | 2012-02-01 |
| Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg (NCT01546558) | Gilead Sciences | 2012-02-01 |
| Proteus Sustained Behavior Change Study (NCT01503008) | Proteus Digital Health, Inc. | 2012-02-01 |
| Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin (NCT01517412) | Sanofi | 2012-02-01 |
| Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes (NCT01630369) | Sanofi | 2012-02-01 |
| Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine (NCT01546597) | Gilead Sciences | 2012-02-01 |
| Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260) (NCT01462266) | Merck Sharp & Dohme LLC | 2012-01-13 |
| Arginase Inhibition in Ischemia-reperfusion Injury (NCT02009527) | Karolinska Institutet | 2012-01-01 |
| A Randomized Cross-over Trial of the Postprandial Effects of Three Different Diets in Patients With Type 2 Diabetes (NCT01522157) | Vårdcentralen Lyckorna | 2012-01-01 |
| Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus (NCT01494987) | Gilead Sciences | 2012-01-01 |
| A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment (NCT01512849) | Tanabe Pharma Corporation | 2012-01-01 |
| Adding Liraglutide to High Dose Insulin: Breaking the Cycle (NCT01505673) | Ildiko Lingvay | 2012-01-01 |
| Empowering Rural African American Women and Communities to Improve Diabetes Outcomes (NCT01806194) | East Carolina University | 2012-01-01 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients (NCT01487109) | Concert Pharmaceuticals | 2012-01-01 |
| Liraglutide and Heart Failure in Type 2 Diabetes (NCT01425580) | Thomas Nystrom | 2012-01-01 |
| Empowering Primary Care Providers and Patients to Improve Chronic Disease Outcomes: The EMPOWER Participatory Action Research (EMPOWER - PAR) (NCT01545401) | Ministry of Health, Malaysia | 2012-01-01 |
| Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting (NCT01326598) | Valeritas, Inc. | 2012-01-01 |
| A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289) (NCT01760447) | Merck Sharp & Dohme LLC | 2011-12-07 |
| Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347) (NCT02194608) | Merck Sharp & Dohme LLC | 2011-12-01 |
| Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy (NCT01474538) | Eli Lilly and Company | 2011-12-01 |
| Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals (NCT01170468) | King Faisal Specialist Hospital & Research Center | 2011-12-01 |
| Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin (NCT01499082) | Sanofi | 2011-12-01 |
| Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus (NCT01449747) | The Catholic University of Korea | 2011-12-01 |
| Evaluation of Continuous Glucose Monitoring in Participants With Type 2 Diabetes Mellitus (MK-0000-258 AM2) (NCT01537120) | Merck Sharp & Dohme LLC | 2011-12-01 |
| Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy (NCT01499095) | Sanofi | 2011-12-01 |
| Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus (NCT01990300) | Takeda | 2011-11-28 |
| The Effects of Hypoglycaemia in People With Type 2 Diabetes (NCT02205996) | University of Hull | 2011-11-01 |
| Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes (NCT01475461) | Pfizer | 2011-11-01 |
| A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes (NCT01474083) | vTv Therapeutics | 2011-11-01 |
| Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients (NCT01476475) | Sanofi | 2011-11-01 |
| Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure (NCT01461577) | Sanofi | 2011-11-01 |
| Bariatric Surgery And Adipose Inflammation Dysfunction and Type 2 Diabetes Mellitus (NCT01882036) | University of Minnesota | 2011-11-01 |
| A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use (NCT01464346) | Medtronic MiniMed, Inc. | 2011-11-01 |
| A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus (NCT01468181) | Eli Lilly and Company | 2011-11-01 |
| A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects (NCT01469468) | Pfizer | 2011-11-01 |
| A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin (NCT01611363) | Astellas Pharma Europe B.V. | 2011-10-27 |
| A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211) (NCT01477853) | Merck Sharp & Dohme LLC | 2011-10-24 |
| Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea (NCT01392677) | AstraZeneca | 2011-10-01 |
| A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy (NCT01447147) | Amgen | 2011-10-01 |
| Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin (NCT01457911) | Sanofi | 2011-10-01 |
| Impact of Web-based Care Management for Poorly Controlled Type 2 Diabetes Mellitus: a Randomized, Controlled Trial (NCT01960062) | Kaiser Permanente | 2011-10-01 |
| Metabolic Effects of Duodenal Jejunal Bypass Liner for Type 2 Diabetes Mellitus (NCT02800668) | Ruhr University of Bochum | 2011-10-01 |
| Telemedicine Strategy With Home Treatment Save Resources (NCT02214017) | Kolding Sygehus | 2011-10-01 |
| Shiga Microalbuminuria Reduction Trial-2 (NCT01461499) | Shiga University | 2011-10-01 |